Bibliotecas PUC-SP - Busca Integrada

XI before X: The Promise of Factor XI Inhibitors

بواسطة Jeffrey I. Weitz, Husam Alzayer
الحاوية / القاعدة Kidney International Reports (2025-01-01)

Antiplatelet therapy in the management of atherothrombosis: recent clinical advances

بواسطة Noel C. Chan, Jeffrey I. Weitz
الحاوية / القاعدة Blood Advances (2018-07-01)

Recent advances in understanding, diagnosing and treating venous thrombosis [version 1; peer review: 2 approved]

بواسطة Noel C Chan, Jeffrey I Weitz
الحاوية / القاعدة F1000Research (2020-10-01)

Anticoagulation for Patients with Venous Thromboembolism: When is Extended Treatment Required?

بواسطة Jeffrey I. Weitz, Paolo Prandoni, Peter Verhamme
الحاوية / القاعدة TH Open (2020-10-01)

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants [version 1; referees: 2 approved]

بواسطة Jeffrey I. Weitz, Iqbal H. Jaffer, James C. Fredenburgh
الحاوية / القاعدة F1000Research (2017-06-01)

Advancements in surface modification strategies of vascular grafts to improve biocompatibility and tissue integration

بواسطة Noor Abu Jarad, Andrew Chami, Jeffrey I. Weitz, Tohid F. Didar
الحاوية / القاعدة Exploration of BioMat-X (2024-09-01)

Trends in the proportion of women as reviewers, editors, and editorial board members of 15 North American and British medical journals from 2014 to 2019: A retrospective study

بواسطة Roxanna Wang, Robin Roberts, James C Fredenburgh, Mary Cushman, Jeffrey I Weitz
الحاوية / القاعدة European Science Editing (2022-07-01)

Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

بواسطة Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz
الحاوية / القاعدة Bleeding, Thrombosis and Vascular Biology (2024-05-01)

Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function.

بواسطة Calvin H Yeh, Alan R Stafford, Beverly A Leslie, James C Fredenburgh, Jeffrey I Weitz
الحاوية / القاعدة PLoS ONE (2016-01-01)

Fibrous hydrogels under biaxial confinement

بواسطة Yang Li, Yunfeng Li, Elisabeth Prince, Jeffrey I. Weitz, Sergey Panyukov, Arun Ramachandran, Michael Rubinstein, Eugenia Kumacheva
الحاوية / القاعدة Nature Communications (2022-06-01)

Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa

بواسطة David A. Donkor, Varsha Bhakta, Louise J. Eltringham-Smith, Alan R. Stafford, Jeffrey I. Weitz, William P. Sheffield
الحاوية / القاعدة Scientific Reports (2017-05-01)

Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors

بواسطة Zoltan Szekanecz, Zhenyu Wang, Jeffrey I Weitz, Christina Charles-Schoeman, Ivana Vranic, David A Martin, Craig Hyde, Burak Sahin, Sara A Paciga
الحاوية / القاعدة RMD Open (2022-11-01)

Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation

بواسطة Paul Y. Kim, Calvin H. Yeh, Brian J. Dale, Beverly A. Leslie, Alan R. Stafford, James C. Fredenburgh, Jack Hirsh, Jeffrey I. Weitz
الحاوية / القاعدة TH Open (2018-04-01)

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin

بواسطة Kochawan Boonyawat, Anthonie W. A. Lensing, Martin H. Prins, Jan Beyer‐Westendorf, Paolo Prandoni, Ida Martinelli, Saskia Middeldorp, Akos F. Pap, Jeffrey I. Weitz, Mark Crowther
الحاوية / القاعدة Research and Practice in Thrombosis and Haemostasis (2021-02-01)

Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome

بواسطة Liping Zhang, Xiaoyu Yan, Partha Nandy, Stefan Willmann, Keith A. A. Fox, Scott D. Berkowitz, Amarnath Sharma, Anne Hermanowski-Vosatka, Stephan Schmidt, Jeffrey I. Weitz, Dirk Garmann, Gary Peters
الحاوية / القاعدة Therapeutic Advances in Cardiovascular Disease (2019-07-01)

Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study

بواسطة Vincent ten Cate, Anthonie W.A. Lensing, Jeffrey I. Weitz, Jan Beyer-Westendorf, Philip S. Wells, Patrick Mismetti, Paolo Prandoni, Alexander T. Cohen, Bruce L. Davidson, Martin H. Prins
الحاوية / القاعدة Haematologica (2019-10-01)

Optimization of plasma-based BioID identifies plasminogen as a ligand of ADAMTS13

بواسطة Hasam Madarati, Veronica DeYoung, Kanwal Singh, Taylor Sparring, Andrew C. Kwong, James C. Fredenburgh, Cherie Teney, Marlys L. Koschinsky, Michael B. Boffa, Jeffrey I. Weitz, Colin A. Kretz
الحاوية / القاعدة Scientific Reports (2024-04-01)

The contact activation system as a potential therapeutic target in patients with COVID‐19

بواسطة Joseph J. Shatzel, Emma P. DeLoughery, Christina U. Lorentz, Erik I. Tucker, Joseph E. Aslan, Monica T. Hinds, David Gailani, Jeffrey I. Weitz, Owen J. T. McCarty, Andras Gruber
الحاوية / القاعدة Research and Practice in Thrombosis and Haemostasis (2020-05-01)

Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients

بواسطة Gary E. Raskob, Alex C. Spyropoulos, Alexander T. Cohen, Jeffrey I. Weitz, Walter Ageno, Yoriko De Sanctis, Wentao Lu, Jianfeng Xu, John Albanese, Chiara Sugarmann, Traci Weber, Concetta Lipardi, Theodore E. Spiro, Elliot S. Barnathan
الحاوية / القاعدة Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2021-03-01)

Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE

بواسطة Walter Ageno, Alfredo Farjat, Sylvia Haas, Jeffrey I. Weitz, Samuel Z. Goldhaber, Alexander G. G. Turpie, Shinya Goto, Pantep Angchaisuksiri, Joern Dalsgaard Nielsen, Gloria Kayani, Sebastian Schellong, Henri Bounameaux, Lorenzo G. Mantovani, Paolo Prandoni, Ajay K. Kakkar
الحاوية / القاعدة Research and Practice in Thrombosis and Haemostasis (2021-02-01)